vs

Side-by-side financial comparison of Canadian Solar Inc. (CSIQ) and Emerson Electric (EMR). Click either name above to swap in a different company.

Canadian Solar Inc. is the larger business by last-quarter revenue ($4.5B vs $4.3B, roughly 1.0× Emerson Electric). Emerson Electric runs the higher net margin — 13.9% vs 1.3%, a 12.6% gap on every dollar of revenue.

Canadian Solar Inc. is a global renewable energy company. Headquartered in Kitchener, Ontario, the company manufactures solar PV modules, provides battery energy storage solutions and develops utility-scale solar power and battery energy storage projects.

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

CSIQ vs EMR — Head-to-Head

Bigger by revenue
CSIQ
CSIQ
1.0× larger
CSIQ
$4.5B
$4.3B
EMR
Higher net margin
EMR
EMR
12.6% more per $
EMR
13.9%
1.3%
CSIQ

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
CSIQ
CSIQ
EMR
EMR
Revenue
$4.5B
$4.3B
Net Profit
$57.6M
$605.0M
Gross Margin
17.5%
53.2%
Operating Margin
2.2%
17.8%
Net Margin
1.3%
13.9%
Revenue YoY
4.1%
Net Profit YoY
3.4%
EPS (diluted)
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSIQ
CSIQ
EMR
EMR
Q4 25
$4.3B
Q3 25
$4.5B
$4.9B
Q2 25
$3.0B
$4.6B
Q1 25
$1.3B
$4.4B
Q4 24
$4.2B
Q3 24
$5.9B
$4.6B
Q2 24
$4.1B
$4.4B
Q1 24
$4.4B
Net Profit
CSIQ
CSIQ
EMR
EMR
Q4 25
$605.0M
Q3 25
$57.6M
$637.0M
Q2 25
$63.6M
$586.0M
Q1 25
$36.2M
$485.0M
Q4 24
$585.0M
Q3 24
$366.8M
$996.0M
Q2 24
$304.4M
$329.0M
Q1 24
$501.0M
Gross Margin
CSIQ
CSIQ
EMR
EMR
Q4 25
53.2%
Q3 25
17.5%
51.9%
Q2 25
18.0%
52.6%
Q1 25
19.0%
53.5%
Q4 24
53.5%
Q3 24
18.0%
51.3%
Q2 24
18.7%
52.8%
Q1 24
52.2%
Operating Margin
CSIQ
CSIQ
EMR
EMR
Q4 25
17.8%
Q3 25
2.2%
16.4%
Q2 25
3.3%
16.1%
Q1 25
3.7%
14.2%
Q4 24
18.6%
Q3 24
7.7%
14.7%
Q2 24
9.1%
10.4%
Q1 24
16.2%
Net Margin
CSIQ
CSIQ
EMR
EMR
Q4 25
13.9%
Q3 25
1.3%
13.1%
Q2 25
2.1%
12.9%
Q1 25
2.7%
10.9%
Q4 24
14.0%
Q3 24
6.2%
21.6%
Q2 24
7.5%
7.5%
Q1 24
11.4%
EPS (diluted)
CSIQ
CSIQ
EMR
EMR
Q4 25
$1.07
Q3 25
$1.12
Q2 25
$1.04
Q1 25
$0.86
Q4 24
$1.02
Q3 24
$1.74
Q2 24
$0.57
Q1 24
$0.87

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSIQ
CSIQ
EMR
EMR
Cash + ST InvestmentsLiquidity on hand
$1.7B
Total DebtLower is stronger
$7.6B
Stockholders' EquityBook value
$3.9B
$20.3B
Total Assets
$13.5B
$41.9B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSIQ
CSIQ
EMR
EMR
Q4 25
Q3 25
$1.7B
Q2 25
$1.7B
Q1 25
$1.7B
Q4 24
Q3 24
$1.9B
Q2 24
$1.9B
Q1 24
Total Debt
CSIQ
CSIQ
EMR
EMR
Q4 25
$7.6B
Q3 25
$8.9B
Q2 25
$8.3B
Q1 25
$8.2B
Q4 24
$6.6B
Q3 24
$7.7B
Q2 24
$7.1B
Q1 24
$7.6B
Stockholders' Equity
CSIQ
CSIQ
EMR
EMR
Q4 25
$20.3B
Q3 25
$3.9B
$20.3B
Q2 25
$3.9B
$19.9B
Q1 25
$3.9B
$19.2B
Q4 24
$20.5B
Q3 24
$3.7B
$21.6B
Q2 24
$3.7B
$20.8B
Q1 24
$20.9B
Total Assets
CSIQ
CSIQ
EMR
EMR
Q4 25
$41.9B
Q3 25
$13.5B
$42.0B
Q2 25
$13.5B
$42.5B
Q1 25
$13.5B
$42.0B
Q4 24
$42.6B
Q3 24
$11.9B
$44.2B
Q2 24
$11.9B
$45.6B
Q1 24
$46.4B
Debt / Equity
CSIQ
CSIQ
EMR
EMR
Q4 25
0.37×
Q3 25
0.44×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.32×
Q3 24
0.36×
Q2 24
0.34×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSIQ
CSIQ
EMR
EMR
Operating Cash FlowLast quarter
$-187.7M
$699.0M
Free Cash FlowOCF − Capex
$602.0M
FCF MarginFCF / Revenue
13.9%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
-3.26×
1.16×
TTM Free Cash FlowTrailing 4 quarters
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSIQ
CSIQ
EMR
EMR
Q4 25
$699.0M
Q3 25
$-187.7M
$3.1B
Q2 25
$1.1B
Q1 25
$241.0M
Q4 24
$777.0M
Q3 24
$3.3B
Q2 24
$1.1B
Q1 24
$743.0M
Free Cash Flow
CSIQ
CSIQ
EMR
EMR
Q4 25
$602.0M
Q3 25
$2.7B
Q2 25
$977.0M
Q1 25
$154.0M
Q4 24
$694.0M
Q3 24
$2.9B
Q2 24
$998.0M
Q1 24
$661.0M
FCF Margin
CSIQ
CSIQ
EMR
EMR
Q4 25
13.9%
Q3 25
54.9%
Q2 25
21.5%
Q1 25
3.5%
Q4 24
16.6%
Q3 24
63.1%
Q2 24
22.8%
Q1 24
15.1%
Capex Intensity
CSIQ
CSIQ
EMR
EMR
Q4 25
2.2%
Q3 25
8.9%
Q2 25
2.0%
Q1 25
2.0%
Q4 24
2.0%
Q3 24
9.1%
Q2 24
2.1%
Q1 24
1.9%
Cash Conversion
CSIQ
CSIQ
EMR
EMR
Q4 25
1.16×
Q3 25
-3.26×
4.86×
Q2 25
1.83×
Q1 25
0.50×
Q4 24
1.33×
Q3 24
3.35×
Q2 24
3.31×
Q1 24
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSIQ
CSIQ

Segment breakdown not available.

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

Related Comparisons